நோயெதிர்ப்பு ஆராய்ச்சி
திறந்த அணுகல்

சுருக்கம்

Immunoinformatics.

Aniekan Jumbo*

Clostridium perfringens is a member of the gastrointestinal tract (GIT) microbial community of both diseased and healthy humans and animals. Also, this bacterium is responsible for around 5–15% of all circumstances of antibiotic-associated diarrhea, which develops in 5–40% of all patients receiving antibiotic therapy. In addition, it causes enteritis necroticans; an often-fatal human disease. C. perfringens is clear anddefined the underlying factors responsible for specific aspects of pathology remains uncertain. This study predicts an effective epitope-based vaccine against fructose 1,6-biphosphatealdolase (FBA) enzyme of Clostridium perfringens using immunoinformatics tools. The sequences were retrieved from NCBI and several prediction tests were conducted to analyze possibleepitopes forB-cell,T-cellMHCclass IandII.Tertiary structure of the most promising epitopes was obtained. 48 epitopes showed high binding affinity for B-cells, while five epitopes showed high binding affinity for MHCI and MHCII. The results were promising to formulate a vaccine with more than 98% population coverage. We hope that these promising epitopes serves as a preventive measure for the disease in the future and recommend in vivo and in vitro studies.